🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Opinions of early- and mid-career investigators on the key challenges and open questions related to each of the fourteen Cancer Hallmarks. #AACR24 #AACR2024 Cancer Discovery

They define a future of cancer team science adopting “radical collaboration”—in which six “Hallmarks of Cancer Collaboration” are utilized to propel cancer teams to reach new levels of productivity and impact in the modern era. #AACR24 #AACR2024 Cancer Discovery aacrjournals.org/cancerdiscover…

Out in nature concurrent with #AACR24 Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer KenOliveLab Ben Stanger Der Lab at UNC nature.com/articles/s4158… nature.com/articles/s4158…

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy | Nature #AACR24 nature.com/articles/s4158…

Biagio Ricciuti, MD PhD from Dana-Farber is presenting today at #AACR2024 section 41 poster 18 new data on wild type KRAS amplification as a de novo oncogenic driver in NSCLC. Terrific work done in collaboration with AmbrogioLab. Mark Awad KRASKickers

Just published with the #AACR24 presentation in Attacking #KRAS Beyond G12C: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers, by Jingjing Jiang, Zhengping Wang, Mallika Singh et al. bit.ly/3vNIQ1A #RevolutionMedicines

Can you believe we got to fund 9 LS1 @ERC_research grants?!?🤩HUGE congratulations to:@clausen_lab, Sonja-Verena Albers,T. Hoppe CECAD Cologne , @Tampe_Lab, Y. Senis Inserm, M. Glickman Biology Technion, M. Foiani IFOM, Photosynthesis Amsterdam & @hecklab! Amazing&very diverse set of projects!

Read the #CancerHallmarks Perspective— Piecing the Puzzle Together. bit.ly/3JnQwuv AmbrogioLab Maria Alcolea @gemmakelly_1 Wai Leong Tam Amanda Lund Lab Ana Luisa Correia Chris Halbrook Stromnes Lab @DanielaQuail Aurelie Ernst Direna Alonso-Curbelo Efrat Shema Susan Bullman Marcus Ruscetti Lab

There's not long left to wait until the EACR Congress comes to the Netherlands in June! ☀️ Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 29 April. 2024.eacr.org

Stunning results from Guillaume Canaud (MD, PhD) who just presented their case study that led to an FDA-approved drug. Thanks Università di Torino for organizing it! #research #24May

There are just a few more days left to register for our upcoming Early-Career Researchers' Conference, happening online 25-26 June! 👉 Don't miss the 12 June deadline: eacr.org/conference/ear…

Mariano Barbacid receive the Mike Price Award ⁦EACR⁩ #EACR2024 👏🏻👏🏻

EACR-@Mark Foundation Postdoctoral Fellowships are awarded for a period of three years and support excellent postdoctoral researchers in laboratories throughout Europe. Is that you? 👀 Apply by 21 August: eacr.org/eacr-fellowshi…

Our PREDICT project is among the 2024 ERC Proof of Concept grants! European Research Council (ERC) #ERCPoC

Happy to share our new publication on redox sensitivities of drug persistent and resistant BRAF mutated lung cancer. GIGA-ULiège Institut Européen de Chimie et Biologie Centro de Investigación del Cáncer/CSIC-USAL-FICUS Santamaria’s Lab AmbrogioLab F.R.S.-FNRS @televie Fondation Léon Fredericq cell.com/cell-reports-m…

Our latest publication online now! rdcu.be/dSvhN Nature Communications Amazing team work Santamaria’s Lab Marie-Julie Nokin Biagio Ricciuti, MD PhD Mark Awad Ernest Nadal Cereda Lab

Excited to co-organize the virtual EACR Boehringer Ingelheim Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others. Details & registration: eacr.org/conference/boe…

I am excited for the next three days of National Cancer Institute's RAS Initiative Symposium 2024. Today, Dr. Kimryn Rathmell Rathmell and AACR Past President Frank McCormick kicked off this important meeting aimed at mobilizing the cancer research community to target RAS-driven cancers.

📖 🎯 A new book! RAS Drug Discovery • Past, Present and Future 🔸️ A comprehensive overview of the state-of-the-art medicinal chemistry approaches towards targeting the formerly undruggable oncogene, KRAS. Anirban Maitra Andres F. Cardona @FredNatLab Dr. Antonio Calles 🫁🚭 Chul Kim

Pls RT: Are you studying the multifaceted MAPK pathway? We would love to hear about your exciting research! Abstract Deadline 👉16.12.2024 for the #virtualmeeting on "Drugging and regulating the #MAPKpathway" organised with EACR with Boehringer Ingelheim eacr.org/conference/boe…